Sionna Therapeutics, Inc.
public_traded
Sionna Therapeutics, Inc. is publicly traded on NASDAQ under ticker SION.
Sionna Therapeutics, Inc. is a biopharmaceutical company. The Company provides treatment paradigm for cystic fibrosis patients by developing medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator.